LETSIMMUN
Lymphocyte Engineering for Therapeutic Synthetic Immunity
Adoptive T cell therapy has advanced to become a distinguished and rapidly evolving translational research field in modern medicine (June et al., 2015). This collaborative research center (CRC) transregio (TRR) LETSIMMUN is setting out to become a hot spot for cutting-edge basic and translation research in Lymphocyte Engineering in Germany, and aspires to deliver novel concepts and cell products for clinical development that provide Therapeutic Synthetic Immunity for patients.
Veranstaltungen
Projekte
Pellentesque pulvinar ac lacus vel egestas. Nunc facilisis libero ornare nulla ullamcorper. Mehr
People
Pellentesque pulvinar ac lacus vel egestas. Nunc facilisis libero ornare nulla ullamcorper. Mehr
Downloads
Pellentesque pulvinar ac lacus vel egestas. Nunc facilisis libero ornare nulla ullamcorper. Mehr
New publication by Veit Buchholz in nature
MYB orchestrates T cell...
New publication on cytotoxic T cells in SARS-CoV2 infection
Recruitment of highly...
Videos
Pellentesque pulvinar ac lacus vel egestas. Nunc facilisis libero ornare nulla ullamcorper. Pellentesque pulvinar ac lacus vel egestas. Nunc facilisis libero ornare nulla ullamcorper.Pellentesque pulvinar ac lacus vel egestas. Nunc facilisis libero ornare nulla ullamcorper. Mehr
Kontakt
Sed ut perspiciatis unde omnis iste natus voluptatem.
Trogerstr.30
81675 München
+4989 4140 6887
m.nauerth@tum.de